Identification of New Prognostic Markers for Breast Cancer.
Condition(s):Breast CancerLast Updated:February 28, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:February 28, 2023Recruiting
Condition(s):Lung CancerLast Updated:March 19, 2020Completed
Condition(s):Lymphoproliferative DisordersLast Updated:February 4, 2021Unknown status
Condition(s):Cancer; Paraneoplastic Syndromes; Neurologic Disorder; Immune System and Related Disorders; Tumor GeneticsLast Updated:May 30, 2019Unknown status
Condition(s):EndometriosisLast Updated:December 13, 2023Active, not recruiting
Condition(s):Pseudoxanthoma ElasticumLast Updated:December 19, 2022Recruiting
Condition(s):Obesity; Insulin ResistanceLast Updated:March 2, 2020Completed
Condition(s):EndometriosisLast Updated:November 21, 2022Enrolling by invitation
Condition(s):ACTH; Cushing’s SyndromeLast Updated:February 23, 2024Recruiting
Condition(s):OverweightLast Updated:January 25, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.